Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT2014051417686N1Phase 2Completed
Phase 2, single-arm trial of levothyroxine sodium in hypothyroidism and dyslipidemia, sponsored by Qom University of Medical Sciences. Primary endpoint: Change in serum lipid profile. Started Mar 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT2014051417686N1.